16th Annual NATA Symposium

16th Annual NATA Symposium, Prague 2015The 16th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis will take place at the Prague Congress Centre in Prague, Czech Republic, on April 16-17, 2015.

The first announcement can be downloaded in PDF or Powerpoint format. A preliminary version of the scientific programme will be released shortly.

The deadline for abstract submission is December 19, 2014. Please click on the link to download an abstract submission form

More information

Follow NATA on LinkedIn and Twitter

Join NATA's goup on LinkedIn and follow NATA on Twitter (@NATAforum) to receive the latest news on patient blood management, haemostasis and thrombosis, and to participate in discussions with colleagues in the field.
LinkedIn Group / Twitter

News from the Industry: White Paper – Red Cell Salvage: Current Status

Intraoperative Red Cell Salvage (RCS) was introduced in the early 1980s and rapidly gained clinical acceptance. Early RCS was done without cell washing, but washed RCS became the standard of care in cardiac surgery and other procedures.

RCS gained popularity because it did not carry the risk of transfusion-transmitted diseases, notably HIV and hepatitis B and C, and decreased demand for allogeneic blood. While both of these benefits are still true today, the increased safety profile of allogeneic transfusion as well as the presence of stable blood inventories have diminished their importance.

Nevertheless, strong clinical and economic reasons remain to use RCS. This white paper addresses these issues.
Read more on this

News

Antidote for rapid reversal of Pradaxa® (dabigatran etexilate) progresses into next stage of clinical investigation with study in patients

On May 22, 2014, Boehringer Ingelheim announced the next step in the clinical development of idarucizumab, an investigational antidote for rapid reversal of dabigatran-induced anticoagulation. Prior clinical research of the antidote in a healthy volunteer study with 145 participants has already demonstrated its potential for immediate, complete and sustained reversal of the anticoagulant effect of dabigatran. Idarucizumab will now be investigated in the clinical setting in patients taking Pradaxa® (dabigatran etexilate).
Read more on this

Transfusion Medicine Becomes NATA's Official Journal

The NATA board of directors has the pleasure to announce that NATA has entered into a partnership with the British Blood Transfusion Society (BBTS) and that Transfusion Medicine, the official journal of BBTS, edited by Dr. David Roberts, has become NATA's official journal.

Online subscription to Transfusion Medicine is granted to NATA members. Please visit the Members Area for more information.
Read more on this

From the Literature

Aug 22, 2014

Published: Jul 2014

Abdul-Kadir R, McLintock C, Ducloy AS, et al.

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel.
Transfusion 2014;54:1756-1768.

#

NATA REVIEW:
This consensus statement developed by an international multidisciplinary expert panel summarises current thinking...
REVIEW by:
B. J. Hunt

Published: Jul 2014

Looney MR, Roubinian N, Gajic O, et al.

Prospective study on the clinical course and outcomes in transfusion-related acute lung injury.
Crit Care Med 2014;42:1676-1687.

#

NATA REVIEW:
Transfusion-related acute lung injury (TRALI) is a serious complication of blood transfusion and has been the...
REVIEW by:
R. Moog

Published: Jun 2014

Aubron C, Reade MC, Fraser JF, Cooper DJ

Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review.
J Crit Care 2014;29:471.e11-471.e17

#

NATA REVIEW:
Aubron and colleagues performed a systematic review of the use of fibrinogen concentrate in trauma and identified...
REVIEW by:
P. Johansson

Published: May 2014

Yamamoto K, Usui A, Takamatsu J

Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair.
J Cardiothorac Surg 2014;9:90.

#

NATA REVIEW:
The authors found that an early goal-directed fibrinogen substitution by fibrinogen concentrate was superior...
REVIEW by:
S. Kozek-Langenecker

Published: May 2014

Lundin ES, Johansson T, Zachrisson H, et al.

Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.
Acta Obstet Gynecol Scand 2014;93:335-344.

#

NATA REVIEW:
This is a well-written prospective randomised study (n = 100) on the effect of a single preoperative...
REVIEW by:
C. Vagianos

Published: May 2014

Lozano M, Mahon A, van der Meer PF, et al.

Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative - UK NEQAS(H) International Exercise.
Vox Sang 2014;106:330-336.

#

NATA REVIEW:
The authors conducted an international laboratory check survey for accuracy of determining platelet counts in...
REVIEW by:
L. T. Goodnough